These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28338626)

  • 21. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
    Ovsyannikova IG; Vierkant RA; Poland GA
    Vaccine; 2006 Jun; 24(25):5381-9. PubMed ID: 16714073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic disposition of ximelagatran and its metabolites in pig; prediction of the impact of membrane transporters through a simple disposition model.
    Sjögren E; Bredberg U; Allard E; Arvidsson B; Bergquist J; Andersson TB; Lennernäs H
    Pharm Res; 2010 Apr; 27(4):597-607. PubMed ID: 20140637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-inflammatory response and adverse drug reactions: mechanisms of action of ximelagatran on chemokine and cytokine activation in a monocyte in vitro model.
    Edling Y; Sivertsson L; Andersson TB; Porsmyr-Palmertz M; Ingelman-Sundberg M
    Toxicol In Vitro; 2008 Sep; 22(6):1588-94. PubMed ID: 18640260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive in silico binding algorithms reveal HLA specificities and autoallergen peptides associated with atopic dermatitis.
    Gong JJ; Margolis DJ; Monos DS
    Arch Dermatol Res; 2020 Nov; 312(9):647-656. PubMed ID: 32152724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis.
    Grunewald J; Kaiser Y; Ostadkarampour M; Rivera NV; Vezzi F; Lötstedt B; Olsen RA; Sylwan L; Lundin S; Käller M; Sandalova T; Ahlgren KM; Wahlström J; Achour A; Ronninger M; Eklund A
    Eur Respir J; 2016 Mar; 47(3):898-909. PubMed ID: 26585430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
    Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
    Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor, are unaffected by a single dose of alcohol.
    Sarich TC; Johansson S; Schützer KM; Wall U; Kessler E; Teng R; Eriksson UG
    J Clin Pharmacol; 2004 Apr; 44(4):388-93. PubMed ID: 15051746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Online capillary solid phase extraction and liquid chromatographic separation with quantitative tandem mass spectrometric detection (SPE-LC-MS/MS) of ximelagatran and its metabolites in a complex matrix.
    Arvidsson B; Allard E; Sjögren E; Lennernäs H; Sjöberg PJ; Bergquist J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):291-7. PubMed ID: 19117807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population.
    Baleotti W; Ruiz MO; Fabron A; Castilho L; Giuliatti S; Donadi EA
    Transfusion; 2014 Oct; 54(10):2468-76. PubMed ID: 24724911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
    Kritikou-Griva E; Spyropoulou-Vlachou M; Tsagarakis NJ; Goumakou E; Vrani V; Galanopoulos A; Papadhimitriou SI; Androutsos G; Paterakis G; Stavropoulos-Giokas C
    Hum Immunol; 2012 Mar; 73(3):278-81. PubMed ID: 22244918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ximelagatran in orthopaedic surgery.
    Eriksson B
    Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():10-7. PubMed ID: 15812199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.
    Steere AC; Klitz W; Drouin EE; Falk BA; Kwok WW; Nepom GT; Baxter-Lowe LA
    J Exp Med; 2006 Apr; 203(4):961-71. PubMed ID: 16585267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires.
    Scholz EM; Marcilla M; Daura X; Arribas-Layton D; James EA; Alvarez I
    Front Immunol; 2017; 8():984. PubMed ID: 28871256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.
    Teng R; Sarich TC; Eriksson UG; Hamer JE; Gillette S; Schützer KM; Carlson GF; Kowey PR
    J Clin Pharmacol; 2004 Sep; 44(9):1063-71. PubMed ID: 15317834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The oral direct thrombin inhibitor Ximelagatran Prophylaxis of venous thromboembolism in hip and knee replacement].
    Mouret P
    Hamostaseologie; 2002 Aug; 22(3):21-4. PubMed ID: 12215757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions.
    Androulakis IP; Nayak NN; Ierapetritou MG; Monos DS; Floudas CA
    Proteins; 1997 Sep; 29(1):87-102. PubMed ID: 9294869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.